Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma

被引：1
|
作者：
Ageenko, Alisa [1 ]
Vasileva, Natalia [1 ,2 ]
Richter, Vladimir [1 ]
Kuligina, Elena [1 ,2 ]
机构：
[1] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Akad Lavrentiev Ave 8, Novosibirsk 630090, Russia
[2] LLC Oncostar, R&D Dept, Ingenernaya St 23, Novosibirsk 630090, Russia
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2024年 / 25卷 / 04期
基金：
俄罗斯科学基金会;
关键词：
glioblastoma; oncolytic viruses; chemotherapy; radiotherapy; immunotherapy; combination therapy; HERPES-SIMPLEX-VIRUS; MEASLES-VIRUS; MALIGNANT GLIOMA; VACCINIA VIRUS; RADIATION-THERAPY; MYXOMA VIRUS; PRECLINICAL EVALUATION; CANCER-CELLS; PHASE-I; GM-CSF;
D O I：
10.3390/ijms25042042
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Glioblastoma is one of the most malignant and aggressive tumors of the central nervous system. Despite the standard therapy consisting of maximal surgical resection and chemo- and radiotherapy, the median survival of patients with this diagnosis is about 15 months. Oncolytic virus therapy is one of the promising areas for the treatment of malignant neoplasms. In this review, we have focused on emphasizing recent achievements in virotherapy, both as a monotherapy and in combination with other therapeutic schemes to improve survival rate and quality of life among patients with glioblastoma.
引用
收藏
页数：26
相关论文
共 50 条
  • [21] Towards personalized oncolytic virotherapy: Differential response of four oncolytic viruses in primary glioblastoma cultures
    Stavrakaki, Eftychia
    Kleijn, Anne
    van den Bossche, Wouter B.
    Balvers, Rutger K.
    Vogelezang, Lisette B.
    Ju, Jie
    Stubbs, Andrew
    Li, Yunlei
    Mustafa, Dana
    Fabro, Federica
    van den Hoogen, Bernadette
    Hoeben, Rob
    Goins, William F.
    Nakashima, Hiroshi
    Chiocca, E. Antonio
    Dirven, Clemens M.
    Lamfers, Martine L.
    CANCER RESEARCH, 2022, 82 (12)
  • [22] Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series
    Gesundheit, Benjamin
    Ben-David, Eliel
    Posen, Yehudit
    Ellis, Ronald
    Wollmann, Guido
    Schneider, E. Marion
    Aigner, Karl
    Brauns, Lars
    Nesselhut, Thomas
    Ackva, Ingrid
    Weisslein, Christine
    Thaller, Arno
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [23] Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses
    Goradel, Nasser Hashemi
    Alizadeh, Arezoo
    Hosseinzadeh, Shahnaz
    Taghipour, Mitra
    Ghesmati, Zeinab
    Arashkia, Arash
    Negahdari, Babak
    FUTURE ONCOLOGY, 2021, 18 (02) : 245 - 259
  • [24] Development of oncolytic virotherapy: from genetic modification to combination therapy
    Qiaoshuai Lan
    Shuai Xia
    Qian Wang
    Wei Xu
    Haiyan Huang
    Shibo Jiang
    Lu Lu
    Frontiers of Medicine, 2020, 14 : 160 - 184
  • [25] Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors
    Sonia Cohen
    Genevieve M. Boland
    Annals of Surgical Oncology, 2022, 29 : 762 - 763
  • [26] Development of oncolytic virotherapy: from genetic modification to combination therapy
    Lan Qiaoshuai
    Xia Shuai
    Wang Qian
    Xu Wei
    Huang Haiyan
    Jiang Shibo
    Lu Lu
    FRONTIERS OF MEDICINE, 2020, 14 (02) : 160 - 184
  • [27] Combination of Oncolytic Virotherapy with Chemotherapy Enhances Breast Cancer Killing
    Nedeljkovic-Kurepa, Ana
    Bhatia, Shilpa
    Curiel, David T.
    Mathis, J. Michael
    MOLECULAR THERAPY, 2009, 17 : S100 - S101
  • [28] Combination Immunotherapy with Vaccine and Oncolytic HSV Virotherapy Is Time Dependent
    Totsch, Stacie K.
    Ishizuka, Andrew S.
    Kang, Kyung-Don
    Gary, Sam E.
    Rocco, Abbey
    Fan, Aaron E.
    Zhou, Li
    Valdes, Pablo A.
    Lee, SeungHo
    Li, Jason
    Peruzzotti-Jametti, Luca
    Blitz, Sarah
    Garliss, Christopher M.
    Johnston, James M.
    Markert, James M.
    Lynn, Geoffrey M.
    Bernstock, Joshua D.
    Friedman, Gregory K.
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (09) : 1273 - 1281
  • [29] Harnessing the Potential of Combination Immunotherapy and Oncolytic Virotherapy for Solid Tumors
    Cohen, Sonia
    Boland, Genevieve M.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (02) : 762 - 763
  • [30] The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma
    Alvarez-Breckenridge, Christopher
    REJUVENATION RESEARCH, 2012, 15 (01) : 106 - 107
12345